C-40 | Procedural Outcomes of Acute Pulmonary Embolism Among Active Cancer Patients: A Nationwide Cohort Analysis

Pulmonary embolism (PE) is one of the most serious complications in cancer patients. There are different treatment modalities for PE patients with very limited data available on outcomes among Patients. This analysis included from National Inpatient Sample between January 2016 and December 2020. We reported baseline characteristics hospital hospitalized modalities. identified 362,749 acute during 2016-2020. Median age was systemic thrombolysis (ST) 70.3%, mechanical thrombectomy (MT) 20.5% Catheter Directed Thrombolysis (CDT) 6.46% surgical Embolectomy (SE) 2.7% (66 vs 68 66 60, p <.0001). Overall, SE associated higher mortality (24% 14.17% 6.67% 20.37%, <.0001), GI bleeding (8% 3.66% 2.50% 3.44%, <.0001 ), major (16% 14.92% 14.61%,p <.0001) utilization ECMO (14% 1.05% 0% 0.31%, compared to (MT,CDT,ST). However ST had highest risk intracranial hemorrhage (2.45% 0.83% 1.83% 0%, p<.0001) (CDT,MT,SE). Patients undergoing longest length median stay (13 days 6 days) inflation-adjusted mean cost ($69,653.93 $33,077.67) other groups. commonly utilized has hemorrhage. least used modality but it rate bleeding.